Proteonomix Announces Termination of Contract with the University of Miami
MarketWatch (press release)
Proteonomix Regenerative Translational Medicine Institute, Inc. (PRTMI) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine.
and more »
More...

LinkBack URL
About LinkBacks


Reply With Quote